Moreover, NRF-2/miR-1 axis-regulated programmed death ligand-1 (PD-L1) inhibits apoptosis of HCC cells, enhances sorafenib resistance and promotes tumor progression (39). This evidence concerns the gene CD274 and hepatocellular carcinoma.